Form 4: Charles Schwab Director Gerri Martin-Flickinger Receives Stock and Option Grants
SEC Form 4 Filing
Director Gerri Martin-Flickinger received stock and option grants from Charles Schwab on May 28, 2024, according to a recent SEC filing.
Summary
- Gerri Martin-Flickinger, a director at Charles Schwab Corp, reported changes in beneficial ownership to the SEC.
- On May 28, 2024, Martin-Flickinger acquired 1,809 shares of common stock and 4,496 nonqualified stock options.
- The stock was granted under the company's 2022 Stock Incentive Plan and vests over three years.
- The options, also granted under the 2022 Stock Incentive Plan, have an exercise price of $70.79 and also vest over three years, expiring on 05/28/2034.
- Following the transaction, Martin-Flickinger directly owns 4,305 shares and indirectly owns 8,455 shares through a trust, as well as 4,496 derivative securities.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices. The grants align the director's interests with shareholders.
Positives
- The grant of stock and options aligns the director's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the director.
Future Outlook
NA
Industry Context
Stock and option grants are a common form of executive compensation in the financial services industry, aligning management's interests with those of shareholders.
Comparison to Industry Standards
- Stock option grants are a typical component of executive compensation packages in the financial services industry.
- Companies like Goldman Sachs, Morgan Stanley, and JP Morgan Chase also utilize stock options and restricted stock units to incentivize their executives.
- The vesting schedules are fairly standard, with many companies using three-year vesting periods.
Stakeholder Impact
- The stock and option grants could have a slightly dilutive effect on existing shareholders.
- The grants incentivize the director to work towards the long-term success of the company, benefiting shareholders.
Key Dates
| Date | Description |
|---|---|
| 2024-01-24 | Power of Attorney executed. |
| 2024-05-28 | Date of stock and option grant. |
| 2024-05-30 | Date of signature on the Form 4 filing. |
| 2034-05-28 | Expiration date of the nonqualified stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.